The Antacid Market is expanding as rising gastrointestinal discomfort and increasing consumer interest in self-care continue to support demand for over-the-counter digestive health products. Market Research Future estimates that the market will increase from USD 7.54 billion in 2025 to USD 10.84 billion by 2035, representing a CAGR of 3.70%.

One of the primary market drivers is the growing prevalence of heartburn, acid reflux, and functional digestive disorders. Lifestyle factors such as unhealthy diets, stress, and irregular meal schedules are increasing the need for accessible symptom-relief products. Heartburn represented the largest indication segment in 2025, accounting for approximately 51% of volume share.

Another significant opportunity is formulation innovation. Manufacturers are introducing gummies, soft chews, effervescent powders, and alginate-based products to meet changing consumer preferences. These formats can provide convenient alternatives to traditional tablets and may attract younger consumers.

E-commerce is also becoming an important growth channel. Online pharmacies and digital retailers offer convenience, broader product selection, competitive pricing, and subscription-based replenishment. According to Market Research Future, e-commerce is projected to expand at a 13.0% CAGR through 2035.

Asia-Pacific presents substantial opportunities because of expanding pharmacy infrastructure, urbanization, and rising healthcare expenditure. India and China are particularly important growth markets. With continued innovation and digital distribution expansion, antacid manufacturers can capitalize on evolving consumer expectations and growing digestive-health awareness.